Learn about Pompe disease
What is Pompe disease?
Pompe disease overview
Clinical presentation and progression
Diagnosis and testing
Disease Management
Multidisciplinary care
Pompe Disease Resources
Watch videos to assist in identifying and diagnosing Pompe disease patients.
Resources and tools
Discover the latest resources and tools to share with your patients.
Care4Rare Patient Program
This service is a free telehealth service giving patients extra support in the management of their condition.
Pompe Disease Patient Alert Card
Download or print a patient alert card designed specifically for patients with Pompe disease to help communicate crucial information about their disease and management to healthcare professionals.
Hereditary Diseases Podcasts
Join clinical experts as they discuss Pompe disease and provide practical insights from their experiences to facilitate timely diagnosis and effective management.
Inspiring science: What's trending?
Stay in the know with the latest trends in science and medicine worldwide through up-to-date
videos, articles and podcasts.
Have an enquiry? Request a visit from a Sanofi representative.
|
PBS Information: MYOZYME. This product is not listed on the PBS. This product is funded under the Life Saving Drugs Program. |
Please review full MYOZYME Product Information before prescribing. Full MYOZYME Product Information is available from sanofi-aventis australia pty ltd here or by contacting 1800 818 806.
|
PBS Information: NEXVIAZYME. This product is not listed on the PBS. This product is funded under the Life Saving Drugs Program. |
Please review full NEXVIAZYME Product Information before prescribing. Full NEXVIAZYME Product Information is available from sanofi-aventis australia pty ltd here or by contacting 1800 818 806.
▼ This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.
Nexviazyme® and Myozyme® are registered trademarks of Sanofi.
MAT-AU-2200627. July 2022